All Online

325 - 336 of 690 results

Refine

Active filters

1 CME CREDIT

This session offers a "state-of-the-art" review of 2019 Addiction Medicine in the context of our current understanding of the addictive process. We will study how neurobiology approaches craving and control, and how these novel concepts inform our treatment options, both pharmacological and psychosocial.


0.287 CME CREDIT

Are opioids effective in chronic pain management? Join neurologist and pain specialist, Dr. Charles Argoff, as he summarizes two recent trials published in JAMA examining the efficacy of opioids in pain management and discusses their clinical implications. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/23/2020 and they are subject to change as new information is published.


1 CME CREDIT

The stark reality is that soon there will not be enough clinicians to care for our citizens sufficiently. Instead of relying on the more traditional and already overburdened one-to-one model, we must adopt technology that enables one-to-many care delivery models. In particular, artificial intelligence (AI) and other emerging technologies allow for outsourcing of routine tasks to machines, creating space in the schedule for human interaction between clinician and patient. With increasing application of these technologies comes greater associated risks, which range from privacy and security to the ethical use of a growing pool of personal health data. As AI and other telehealth tools intersect with care delivery, how can we minimize the risks while improving care delivery, patient and clinician satisfaction, and clinical outcomes?


0.368 CME CREDIT

Pain Points: Best Practices for Tapering of Opioids

0.25 CME/MOC
0.37 AANP | 0.37 Pharmacology

Do you have questions about how to approach tapering opioid medications? Join neurologist and pain specialist, Dr. Charles Argoff, as he reviews a recent expert consensus statement published in Mayo Clinic Proceedings that provides guidance to clinicians about safe opioid tapering. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/23/2020 and they are subject to change as new information is published. /


1.5 CME CREDITS

Strategies for Effective Pain Management: The Basics

1.50 CME/MOC
1.50 AANP | 0.38 Pharmacology

This activity will discuss the epidemiology and pathophysiology of acute and chronic pain, patient assessment, assessment of risk for opioid-related aberrant behaviors, nonpharmacologic approaches to pain management, and non-opioid analgesics. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 3/19/2020 and they are subject to change as new information is published.


1 CME CREDIT

It is important to recognize and address cognitive complaints and dementia symptoms early in the disease continuum and as part of routine care. Steps to diagnose mild cognitive impairment and Alzheimer’s disease will be discussed, as will the importance of early treatment. Approaches to Alzheimer’s disease prevention, including lifestyle changes, will be presented, along with emerging disease-modifying therapies.


0.275 CME CREDIT

Join neurologist and pain specialist, Dr. Charles Argoff, as he discusses a recent expert consensus on best practices in performing a pain assessment—including appropriate components of the physical exam—via telemedicine. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/23/2020 and they are subject to change as new information is published.


healthcare provider counselling a person with obesity
0.25 CME CREDIT

Traversing the Chasm: Overcoming Challenges of Obesity Management in Primary Care: Module 2

An Adaptive Learning Experience

0.25 CME/MOC
0.25 AANP | 0.25 Pharmacology

Obesity is a growing epidemic in the United States, and effective treatment of this chronic disease requires evidence-based implementation of treatment approaches. This activity will discuss best practices for approaching the person with obesity and individualizing obesity treatment plans. It will include weight loss pharmacotherapy and approaches to address and overcome barriers to weight loss.


0.75 CME CREDIT

A patient presents with joint pains. How should we approach the history, physical examination, laboratory tests, and imaging studies to arrive at a correct diagnosis? The discussion points out how to differentiate between rheumatoid arthritis, psoriatic arthritis, lupus and fibromyalgia to correctly diagnose these conditions.


0.75 CME CREDIT

In this session faculty will discuss pertinent updates for the primary care provider related to community acquired pneumonia (CAP). Dr. Ellie JC Goldstein will walk you through the bacteria which leads to CAP, in order to help understand how this disease evolves. He will describe the most up to date testing and treatment guidelines and explain who procalcitonin can play a role in the diagnosis and management of CAP. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/18/2020, and they are subject to change as new information is published.


0.5 CME CREDIT

This session covers a variety of recent publications that contradict many of the current eating trends and fads in western diets. Debunking the hype and assumption that the internet and many advertisements tell our patients is the focus. The session ends with a simple 5 step process to help all patients who want to lose weight.


0.36 CME CREDIT

Cannabinoids: What PCPs Need to Know to Keep Patients Safe

0.25 CME/MOC
0.36 AANP | 0.36 Pharmacology

As cannabis products become increasingly popular and gain legality throughout the United States, it can be confusing to understand the difference between those your patient can purchase at the corner store vs. FDA-approved products. This webcast will explain those distinctions as well as discuss safety concerns with the use of cannabis products. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/11/2020 and they are subject to change as new information is published.